Blocking artery plus surgery offers hope for reducing reoperations in brain hematoma patients

Injection of a substance to block an artery feeding the dura (protective sack around the brain) along with surgery to remove pooled blood reduced the risk that patients will require repeat surgery compared to surgical drainage alone, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2024.

Compliance standards in medicines are evolving rapidly. How can CDMOs keep up? – Pharmaceutical Technology

The regulatory framework governing medicine development is in flux. Technology innovation, consumer adoption of digital therapeutic interventions and the move towards personalised medicine are some

June 23, 2023

Pelago Secures $58M to Expand Substance Use Management as an Employee Benefit

What You Should Know: Pelago the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced $58 million in new

March 29, 2024

Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication

The FDA approved label expansions for bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet) so they can be used more broadly as cardiovascular prevention drugs, Esperion

March 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.